Infliximab maintenance therapy for fistualising Crohn's disease (Record no. 524)
000 -LEADER | |
---|---|
fixed length control field | 00594cas a2200157 a 4500 |
001 - CONTROL NUMBER | |
control field | J-000489 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 120123s9999 xx r poo 0 0eng d |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | eng |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Sands, B. |
222 #0 - KEY TITLE | |
Key title | New England Journal of Medicine |
245 00 - TITLE STATEMENT | |
Title | Infliximab maintenance therapy for fistualising Crohn's disease |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 876-885 |
500 ## - GENERAL NOTE | |
General note | Journal print article |
520 3# - SUMMARY, ETC. | |
Summary, etc | Patients with fistualising Crohn's disease have an increased likelihood of a continued response over a 54 week period if infliximab treatment is continued every 8 weeks. 3 tabs 2 figs. |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Crohn's disease |
Withdrawn status | Lost status | Damaged status | Not for loan | Permanent Location | Current Location | Date acquired | Serial Enumeration / chronology | Date last seen | Copy number | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|
BHPI CRP LIbrary | BHPI CRP LIbrary | 2013-05-25 | 350, 9, 26 February, 2004. | 2013-05-25 | 1 | 2013-05-25 | Journals, eBooks, Papers, Articles, Magazines |